Production

  1. Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes 10/10/2024

    Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.

  2. How To Choose A Capping Method In MRNA Production 2/24/2023

    Is your mRNA production process ready for scale up? Learn how to choose a capping method to optimize your mRNA yield and process costs.

  3. CESS Technology 10/20/2020

    Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.

  4. Meet The Experts: Part 2 - Raman Spectroscopy 5/1/2023

    Watch part 2 of this 4-part interview series to explore Raman spectroscopy, one of the main PAT tools for monitoring bioprocess CQAs and CPPs, with expert Fabien Caron.

  5. Using An Adherent Platform To Scale-Up An Upstream Viral Vector Process 11/20/2024

    Gain insight into a helper-dependent adenovirus (HDAd) process that covers everything from bench-scale and optimization to tech transfer.

  6. How An Optimized Purification Platform Can Speed mAbs Clinical Production 4/3/2023

    Explore how a purification development platform, including a mixed-mode chromatography step, allowed Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.

  7. Your Contract Manufacturer Partner 12/14/2020

    Discover an integrated solution for pharmaceutical companies that offers a broad range of manufacturing services and capabilities to produce high-quality devices.

  8. Bioburden And EU GMP Annex 1: Risk Assessment, Reduction, And Testing

    Experts on regulation, filtration, sampling, and quality control discuss risk assessment and filtration-based strategies to reduce bioburden.

  9. Strategies For Scaling Up mRNA Manufacturing 4/11/2022

    The clinical promise of mRNA therapeutics and vaccines is clear, but compared to monoclonal antibodies or viral vectors, their novelty also brings new challenges to the manufacturing process.

  10. Thermo Fisher Scientific Single-Use Global Manufacturing Network 4/18/2022

    We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.